HSP2MAG-63K

MILLIPLEX^® Human Sepsis Magnetic Bead Panel 2 - Immune Response Multiplex Assay

Inflammation/Immunology Bead-Based Multiplex Assays using the Luminex technology enables the simultaneous analysis of multiple sepsis biomarkers in human serum, plasma and cell culture samples.

• UNSPSCコード: 12161503
• eCl@ss: 32161000
• NACRES: NA.84

特性

• 品質水準: 200
• 交差性: human
• メーカー／製品名: Milliplex^®
• assay range: accuracy: 87%; (MIP-1β); accuracy: 92%; (MIP-1α); accuracy: 95%; (Granzyme B); accuracy: 98%; (IL-8); standard curve range: 10-10,000 pg/mL; (IL-1α and MIP-1β); standard curve range: 195-200,000 pg/mL; (MMP-8); standard curve range: 2,930-3,000,000 pg/mL; (HSP70); standard curve range: 2-2,000 pg/mL; (Granzyme B); standard curve range: 5-5,000 pg/mL; (IL-8 and MIP-1β)
• テクニック: multiplexing: suitable
• 検出方法: fluorometric (Luminex xMAP)
• 輸送温度: wet ice

詳細

詳細

Sepsis or SIRS (systemic inflammatory response syndrome) results from infection, whether bacterial, viral, fungal, or parasitic. According to the CDC, sepsis is the second leading cause of death in non-coronary ICU patients in the U.S. The pathogenesis of sepsis is very complex. Both an innate and acquired immune response to infection interrupts homeostasis with a shift of cytokine expression that increases immunosuppression. In addition, migration of the leukocytes in the inflamed tissues secretes a tissue factor leading to the formation of thrombin, also triggering the release of chemokines and adhesion molecules through endothelial cells. Severe sepsis occurs when hypotension or hypoperfusion to one or more organs leads to organ dysfunction, which, in turn, can cause septic shock, multiple organ dysfunction syndrome (MODS) and death.

MILLIPLEX^® Human Sepsis Panel 2 is to be used for the simultaneous quantification of any or all of the following analytes in human serum, plasma and cell / tissue culture supernatant samples: Granzyme B, HSP70, IL-1α, IL-8/CXCL8, MIP-1α/CCL3, MIP-1β/CCL4, MMP-8. This kit uses a 96-well format, contains a lyophilized standard cocktail, two internal assay quality controls and can measure up to 38 samples in duplicate.

The Luminex^® xMAP^® platform uses a magnetic bead immunoassay format for ideal speed and sensitivity to quantitate multiple analytes simultaneously, dramatically improving productivity while conserving valuable sample volume.

Panel Type: Immune Response

アプリケーション

• Analytes: Granzyme B, HSP70, IL-1α, IL-8, MIP-1α, MIP-1β, MMP-8
• Recommended Sample type: Serum, plasma, or cell culture supernatant
• Recommended Sample dilution: Neat
• Assay Run Time: One day Research Category: Inflammation & Immunology

特徴および利点

Design your multiplex kit by choosing available analytes within this panel.

その他情報

Sensitivity: Refer to kit protocol for individual sensitivities.

法的情報

Luminex is a registered trademark of Luminex Corp

MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany

xMAP is a registered trademark of Luminex Corp

安全性情報

• ピクトグラム: GHS06,GHS08,GHS05,GHS09
• シグナルワード: Danger
• 危険有害性情報: H302 + H332,H311,H317,H318,H373,H411
• 注意書き: P273 - P280 - P302 + P352 + P312 - P304 + P340 + P312 - P305 + P351 + P338 - P314
• 危険有害性の分類: Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2
• ターゲットの組織: Respiratory Tract
• 保管分類コード: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects